Our Team

Dr. Konstantinos Alevizopoulos | Partner

Dr. Konstantinos Alevizopoulos joined Ventac Partners as a Partner in August 2008. He brings significant expertise in the identification, licensing and development of early therapeutic and diagnostic leads in the life sciences sector. While implementing key preclinical research & development strategies, Dr. Alevizopoulos has worked closely with leading academic institutions, teaching hospitals and CROs around the globe to create significant shareholder value and forward potential for investors.

Important positions in his curriculum outside Ventac Partners include:  Managing Director and Head of R & D of Medexis SA (GR), Chief Scientific Officer of Gerolymatos International SA (GR) and Head of R & D of Apotech Corporation (CH). He has also been a founding partner of ECG Biotechnology Consulting Group (CH) and of the Hellenic  Biotechnology Cluster (GR).

Dr. Alevizopoulos received his Biology degree from the University of Athens, Greece and his Ph.D. in Molecular Biology from the University of Lausanne, Switzerland. He has also conducted post-doctoral studies in the Swiss Institute of Experimental Cancer Research (Switzerland) and the Schering Plough Research Institute (USA) specializing in preclinical oncology research. Dr. Alevizopoulos is trained in European Patent Law (Robert Schuman University of Strasbourg, France).

Konstantinos Alevizopoulos, PhD
Partner